Global Cancer registry software Market 2023-2027

Description

List of Tables

The cancer registry software market is forecasted to grow by USD 82.3 mn during 2022-2027, accelerating at a CAGR of 12.13% during the forecast period. The report on the cancer registry software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, growing number of cancer registries, and increasing partnerships to improve cancer registries.

Technavio's cancer registry software market is segmented as below:

By End-user

Government and third party
Pharma biotech and medical device comp.
Hospitals and medical practice
Private payers
Research institutes

By Type

Stand-alone software
Integrated software

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing clinical research for oncology as one of the prime reasons driving the cancer registry software market growth during the next few years. Also, rising integration of AI and machine learning and increasing adoption of EHRs for cancer registries will lead to sizable demand in the market.

The report on the cancer registry software market covers the following areas:

Cancer registry software market sizing
Cancer registry software market forecast
Cancer registry software market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer registry software market vendors that include CDC, Conduent Inc., Elekta AB, ERS Inc., Inspirata Inc., International Association of Cancer Registries, International Business Machines Corp., McKesson Corp., NeuralFrame Inc., OMH HealthEdge Holdings LLC, Onco Inc., Ordinal Data Inc., Redsson Ltd., Siemens Healthineers AG, and University of Utah Health. Also, the cancer registry software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40838

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global cancer registry software market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global cancer registry software market 2017 - 2021 ($ million)
4.2 End User Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End User Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Government and third party - Market size and forecast 2022-2027
Exhibit 34: Chart on Government and third party - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Government and third party - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Government and third party - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Government and third party - Year-over-year growth 2022-2027 (%)
6.4 Pharma biotech and medical device companies - Market size and forecast 2022-2027
Exhibit 38: Chart on Pharma biotech and medical device companies - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Pharma biotech and medical device companies - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Pharma biotech and medical device companies - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Pharma biotech and medical device companies - Year-over-year growth 2022-2027 (%)
6.5 Hospitals and medical practice - Market size and forecast 2022-2027
Exhibit 42: Chart on Hospitals and medical practice - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Hospitals and medical practice - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Hospitals and medical practice - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Hospitals and medical practice - Year-over-year growth 2022-2027 (%)
6.6 Private payers - Market size and forecast 2022-2027
Exhibit 46: Chart on Private payers - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Private payers - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Private payers - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Private payers - Year-over-year growth 2022-2027 (%)
6.7 Research institutes - Market size and forecast 2022-2027
Exhibit 50: Chart on Research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Research institutes - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Research institutes - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by End-user
Exhibit 54: Market opportunity by End-user ($ million)
Exhibit 55: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 56: Chart on Type - Market share 2022-2027 (%)
Exhibit 57: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 58: Chart on Comparison by Type
Exhibit 59: Data Table on Comparison by Type
7.3 Stand-alone software - Market size and forecast 2022-2027
Exhibit 60: Chart on Stand-alone software - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Stand-alone software - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Stand-alone software - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Stand-alone software - Year-over-year growth 2022-2027 (%)
7.4 Integrated software - Market size and forecast 2022-2027
Exhibit 64: Chart on Integrated software - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Integrated software - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Integrated software - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Integrated software - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 68: Market opportunity by Type ($ million)
Exhibit 69: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 Italy - Market size and forecast 2022-2027
Exhibit 99: Chart on Italy - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Italy - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Italy - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 CDC
Exhibit 119: CDC - Overview
Exhibit 120: CDC - Product / Service
Exhibit 121: CDC - Key offerings
12.4 Conduent Inc.
Exhibit 122: Conduent Inc. - Overview
Exhibit 123: Conduent Inc. - Business segments
Exhibit 124: Conduent Inc. - Key news
Exhibit 125: Conduent Inc. - Key offerings
Exhibit 126: Conduent Inc. - Segment focus
12.5 Elekta AB
Exhibit 127: Elekta AB - Overview
Exhibit 128: Elekta AB - Business segments
Exhibit 129: Elekta AB - Key news
Exhibit 130: Elekta AB - Key offerings
Exhibit 131: Elekta AB - Segment focus
12.6 ERS Inc.
Exhibit 132: ERS Inc. - Overview
Exhibit 133: ERS Inc. - Product / Service
Exhibit 134: ERS Inc. - Key offerings
12.7 Inspirata Inc.
Exhibit 135: Inspirata Inc. - Overview
Exhibit 136: Inspirata Inc. - Product / Service
Exhibit 137: Inspirata Inc. - Key offerings
12.8 International Association of Cancer Registries
Exhibit 138: International Association of Cancer Registries - Overview
Exhibit 139: International Association of Cancer Registries - Product / Service
Exhibit 140: International Association of Cancer Registries - Key offerings
12.9 International Business Machines Corp.
Exhibit 141: International Business Machines Corp. - Overview
Exhibit 142: International Business Machines Corp. - Business segments
Exhibit 143: International Business Machines Corp. - Key news
Exhibit 144: International Business Machines Corp. - Key offerings
Exhibit 145: International Business Machines Corp. - Segment focus
12.10 McKesson Corp.
Exhibit 146: McKesson Corp. - Overview
Exhibit 147: McKesson Corp. - Business segments
Exhibit 148: McKesson Corp. - Key offerings
Exhibit 149: McKesson Corp. - Segment focus
12.11 NeuralFrame Inc.
Exhibit 150: NeuralFrame Inc. - Overview
Exhibit 151: NeuralFrame Inc. - Product / Service
Exhibit 152: NeuralFrame Inc. - Key offerings
12.12 OMH HealthEdge Holdings LLC
Exhibit 153: OMH HealthEdge Holdings LLC - Overview
Exhibit 154: OMH HealthEdge Holdings LLC - Product / Service
Exhibit 155: OMH HealthEdge Holdings LLC - Key offerings
12.13 Onco Inc.
Exhibit 156: Onco Inc. - Overview
Exhibit 157: Onco Inc. - Product / Service
Exhibit 158: Onco Inc. - Key offerings
12.14 Ordinal Data Inc.
Exhibit 159: Ordinal Data Inc. - Overview
Exhibit 160: Ordinal Data Inc. - Product / Service
Exhibit 161: Ordinal Data Inc. - Key offerings
12.15 Redsson Ltd.
Exhibit 162: Redsson Ltd. - Overview
Exhibit 163: Redsson Ltd. - Product / Service
Exhibit 164: Redsson Ltd. - Key offerings
12.16 Siemens Healthineers AG
Exhibit 165: Siemens Healthineers AG - Overview
Exhibit 166: Siemens Healthineers AG - Business segments
Exhibit 167: Siemens Healthineers AG - Key news
Exhibit 168: Siemens Healthineers AG - Key offerings
Exhibit 169: Siemens Healthineers AG - Segment focus
12.17 University of Utah Health
Exhibit 170: University of Utah Health - Overview
Exhibit 171: University of Utah Health - Product / Service
Exhibit 172: University of Utah Health - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations